drugs glp 1 Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds Can one drug do it

doi: 10.1016/j.molmet.2018.09.009 29 KimSJNianCKarunakaranSCleeSMIsalesCMMcIntoshCH

This pattern continued when assessing the risk for atrial fibrillation, as the GLP-1 group had a significantly decreased risk for this outcome vs

Semaglutide: First global approval

This is relevant for the short-acting GLP-1 agonists, whereas tachyphylaxis rapidly develops for the long-acting agonists [8]

In this context, a phase 2 trial involving patients with obesity and T2DM reported noteworthy results

Additionally, within the case series results, one patient (2.6%) died, while 2.7% of ICSRs from our FAERS analysis had a fatal outcome, underscoring the seriousness of acute pancreatitis and the necessity for specialized attention